LFCR logo

LFCR
Lifecore Biomedical Inc

647
Mkt Cap
$324.83M
Volume
144,966.00
52W High
$8.98
52W Low
$4.76
PE Ratio
-6.56
LFCR Fundamentals
Price
$8.56
Prev Close
$8.67
Open
$8.67
50D MA
$7.95
Beta
1.81
Avg. Volume
165,666.05
EPS (Annual)
-$1.27
P/B
-30.44
Rev/Employee
$317,406.40
Loading...
Loading...
News
all
press releases
Lifecore Biomedical (NASDAQ:LFCR) Trading 2.8% Higher - Here's Why
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 2.8% - Time to Buy...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If...
Business Wire·14d ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Stock Rating Upgraded by Zacks Research
Zacks Research raised Lifecore Biomedical to a "hold" rating in a research report on Thursday...
MarketBeat·26d ago
News Placeholder
Lifecore Biomedical (LFCR) Projected to Post Quarterly Earnings on Thursday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing its Q2 2026 earnings after the market closes on Thursday, January 1. (View Earnings Report at...
MarketBeat·1mo ago
News Placeholder
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM...
PR Newswire·1mo ago
News Placeholder
734,533 Shares in Lifecore Biomedical, Inc. $LFCR Bought by Grizzlyrock Capital LLC
Grizzlyrock Capital LLC purchased a new stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·2mo ago
News Placeholder
22NW LP Sells 1,490,981 Shares of Lifecore Biomedical, Inc. $LFCR
22NW LP lowered its position in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 84.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned...
MarketBeat·2mo ago
News Placeholder
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If...
Business Wire·2mo ago
News Placeholder
Q4 Earnings Forecast for LFCR Issued By Barrington Research
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities researchers at Barrington Research issued their Q4 2025 earnings per share (EPS) estimates for Lifecore Biomedical in a research...
MarketBeat·3mo ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Releases Earnings Results, Beats Estimates By $0.01 EPS
Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus...
MarketBeat·3mo ago
<
1
2
...
>

Latest LFCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.